| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of P13 kinase p110 delta. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding P13 kinase p110 delta. Methods of using these compounds for modulation of P13 kinase p110 delta expression and for treatment of diseases associated with expression of P13 kinase p110 delta are provided. |